For example, UBE2C is highly expressed in gastric cancer, and inhibition of UBE2C expression decreases the development of gastric adenocarcinoma through the Wnt/β-catenin and PI3K/Akt signaling pathways [35]. This evidence concerns the gene UBE2C and gastric adenocarcinoma.